Research ArticleRESEARCH

Preparation and Characterization of Papaverine-Loaded Poly[(R)-3-Hydroxybutyrate] Membranes To Be Used in the Prevention of Vasospasm

Eylem Güven, Eşref Oǧuz Güven, Cem Bayram, Osman Nuri Kazak and Emir Baki Denkbaş
PDA Journal of Pharmaceutical Science and Technology July 2010, 64 (4) 316-326;

References

  1. 1.↵
    1. Bentley K. W.
    The Isoquinoline Alkaloids; Harwood Academic Publishers: Amsterdam, 1998.
  2. 2.↵
    1. Miyamoto M.,
    2. Takayanagi I.,
    3. Ohkubo H.,
    4. Takagi K.
    Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases. Jpn. J. Pharmacol. 1976, 26 (1), 114–117.
    OpenUrl
  3. 3.↵
    1. Duckwiler G.
    Balloon angioplasty and intra-arterial papaverine for vasospasm. J. Stroke Cerebrovasc. Dis. 1997, 6 (4), 261–263.
    OpenUrlPubMed
  4. 4.↵
    1. Dalbasti T.,
    2. Özdamar N.,
    3. Oktar N.
    Local application of controlled release papaverine in vasospasm treatment. Clinical Neurology and Neurosurgery 1997, 99 (supp. 1), 194.
    OpenUrl
  5. 5.↵
    1. Takanashi Y.,
    2. Ishida T.,
    3. Meguro T.,
    4. Kirchmeier M. J.,
    5. Allen T. M.,
    6. Zhang J. H.
    Intrathecal application with liposome-entrapped Fasudil for cerebral vasospasm following subarachnoid hemorrhage in rats. J. Clin. Neurosci. 2001, 8 (6), 557–561.
    OpenUrlPubMed
  6. 6.↵
    1. Occhinorelli S.,
    2. De Tullio D.,
    3. Pellegrini D.,
    4. Ascanelli S.,
    5. Resta G.,
    6. Stano R.,
    7. Messina F.,
    8. Azzena G.
    Arteriovenous fistulas for hemodialysis created using a long-term absorbable suture: a safe solution and a measure to minimize myointimal hyperplasia. J. Vasc. Access 2005, 6 (4), 171–176.
    OpenUrlPubMed
  7. 7.↵
    1. Ghosh J.,
    2. Baguneid M.,
    3. Khwaja N.,
    4. Murphy M. O.,
    5. Turner N.,
    6. Halka A.,
    7. Ferguson M. W.,
    8. Kielty C. M.,
    9. Walker M. G.
    Reduction of myointimal hyperplasia after arterial anastomosis by local injection of transforming growth factor beta3. J. Vasc. Surg. 2006, 43 (1), 142–149.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Neville R. F.,
    2. Sidawy A. N.
    Myointimal hyperplasia: basic science and clinical considerations. Semin. Vasc. Surg. 1998, 11 (3), 142–148.
    OpenUrlPubMed
  9. 9.↵
    1. Haruguchi H.,
    2. Teraoka S.
    Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a review. J. Artif. Organs 2003, 6 (4), 227–235.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Attaran S.,
    2. John L.,
    3. El-Gamel A.
    Clinical and potential use of pharmacological agents to reduce radial artery spasm in coronary artery surgery. Ann. Thorac. Surg. 2008, 85 (4), 1483–1489.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Akin E. B.,
    2. Topçu O.,
    3. Ozcan H.,
    4. Ersöz S.,
    5. Aytaç S.,
    6. Anadol E.
    Hemodynamic effect of transdermal glyceryl trinitrate on newly constructed arteriovenous fistula. World J. Surg. 2002, 26 (10), 1256–1259.
    OpenUrlPubMed
  12. 12.↵
    1. Loh X. J.,
    2. Tan K. K.,
    3. Li X.,
    4. Li J.
    The in vitro hydrolysis of poly(ester urethane)s consisting of poly[(R)-3-hydroxybutyrate] and poly(ethylene glycol). Biomaterials 2006, 27 (9), 1841–1850.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Xu J.,
    2. Guo B. H.,
    3. Yang R.,
    4. Wu Q.,
    5. Chen G. Q.,
    6. Zhang Z. M.
    In situ FTIR study on melting and crystallization of polyhydroxyalkanoates. Polymer 2002, 43 (25), 6893–6899.
    OpenUrl
  14. 14.↵
    1. Doi Y.
    Microbial Polyester; VCH Publishers: New York, 1990.
  15. 15.↵
    1. Saito T.,
    2. Tomita K.,
    3. Juni K.,
    4. Ooba K.
    In vivo and in vitro degradation of poly(3-hydroxybutyrate) in rat. Biomaterials 1991, 12 (3), 309–312.
    OpenUrlPubMed
  16. 16.↵
    1. Gogolewski S.,
    2. Jovanovic M.,
    3. Perren S. M.,
    4. Dillon J. G.,
    5. Hughes M. K.
    Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J. Biomed. Mater. Res. 1993, 27 (9), 1135–1148.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Reusch R. N.,
    2. Sparrow A. J.,
    3. Gardiner J.
    Transport of poly betahydroxybutyrate in human plasma. Biochim. Biophys. Acta 1992, 1123 (1), 33–40.
    OpenUrlPubMed
  18. 18.↵
    1. Öztürk E.,
    2. Ergün M. A.,
    3. Öztürk Z.,
    4. Nurözler A. B.,
    5. Keçeci K.,
    6. Özdemir N.,
    7. Denkbaş E. B.
    Chitosan-coated alginate membranes for cultivation of limbal epithelial cells to use in the restoration of damaged corneal surfaces. Int. J. Artif. Organs 2006, 29 (2), 228–238.
    OpenUrlPubMed
  19. 19.↵
    1. Lin W. C.,
    2. Liu T. Y.,
    3. Yang M. C.
    Hemocompatibility of polyacrylonitrile dialysis membrane immobilized with chitosan and heparin conjugate. Biomaterials 2004, 25 (10), 1947–1957.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Schulz H.,
    2. Baranska M.,
    3. Quilitzsch R.,
    4. Schütze W.
    Determination of alkaloids in capsules, milk and ethanolic extracts of poppy (Papaver somniferum L.) by ATR-FT-IR and FT-Raman spectroscopy. Analyst 2004, 129 (10), 917–920.
    OpenUrlPubMed
  21. 21.↵
    1. Kecskemeti G.,
    2. Smausz T.,
    3. Kresz N.,
    4. Toth Z.,
    5. Hopp B.,
    6. Chrisey D.,
    7. Berkesi O.
    Pulsed laser deposition of polyhydroxybutyrate biodegradable polymer thin films using ArF excimer laser. Applied Surface Science 2006, 253 (3), 1185–1189.
    OpenUrl
  22. 22.↵
    1. Jivraj I. I.,
    2. Martini L. G.,
    3. Thomson C. M.
    An overview of different excipients useful for direct compression of tablets. Pharm. Sci. Technol. Today 2000, 3 (2), 58–63.
    OpenUrlPubMed
  23. 23.↵
    1. Ramirez M.,
    2. Leopoldo C.,
    3. Robles V.
    Effect of formulation variables on Verapamil Hydrochloride release from hydrated HPMC matrices. Rev. Soc. Quim. Mex. 2004, 48, 326–331.
    OpenUrl
  24. 24.↵
    1. Amidon G. L.,
    2. Lee P. I.,
    3. Topp E. M.
    1. Kou J. H.
    Transport in Polymer Systems. In Transport Processes in Pharmaceutical Systems; Amidon G. L., Lee P. I., Topp E. M., Eds.; Marcel Dekker: New York, 2000; p 451.
  25. 25.↵
    1. Denkbaş E. B.,
    2. Odabaşı M.
    Chitosan microspheres and sponges: Preparation and characterization. J. Appl. Polym. Sci. 2000, 76 (11), 1637–1643.
    OpenUrlCrossRef
  26. 26.↵
    1. Denkbaş E. B.,
    2. Seyyal M.,
    3. Pişkin E.
    5-Fluorouracil loaded chitosan microspheres designed for chemoembolization. J. Microencapsul. 1999, 16 (6), 741–749.
    OpenUrlPubMed
  27. 27.↵
    1. Cui F.,
    2. Cun D.,
    3. Tao A.,
    4. Yang M.,
    5. Shi K.,
    6. Zhao M.,
    7. Guan Y.
    Preparation and characterization of melittin-loaded poly (dl-lactic acid) or poly (dl-lactic-co-glycolic acid) microspheres made by the double emulsion method. J. Controlled Release 2005, 107 (2), 310–319.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Ha J. H.,
    2. Kim S. H.,
    3. Han S. Y.,
    4. Sung Y. K.,
    5. Lee Y. M.,
    6. Kang I. K.,
    7. Cho C. S.
    Albumin release from bioerodible hydrogels based on semi-interpenetrating polymer networks composed of poly(o-caprolactone) and poly(ethylene glycol) macromer. J. Controlled Release 1997, 49 (2–3), 253–262.
    OpenUrlCrossRef
  29. 29.↵
    1. Cho C. S.,
    2. Han S. Y.,
    3. Ha J. H.,
    4. Kim S. H.,
    5. Lim D. Y.
    Clonazepam release from bioerodible hydrogels based on semi-interpenetrating polymer networks composed of poly(o-caprolactone) and poly(ethylene glycol) macromer. Int. J. Pharm. 1999, 181 (2), 235–242.
    OpenUrlPubMed
  30. 30.↵
    1. Peng H.,
    2. Zhou S.,
    3. Guo T.,
    4. Li Y.,
    5. Li X.,
    6. Wang J.,
    7. Weng J.
    In vitro degradation and release profiles for electrospun polymeric fibers containing paracetanol. Colloids Surf. B Biointerfaces 2008, 66 (2), 206–212.
    OpenUrlPubMed
  31. 31.↵
    1. Yoshioka T.,
    2. Tsuru K.,
    3. Hayakawa S.,
    4. Osaka A.
    Preparation of alginic acid layers on stainless-steel substrates for biomedical applications. Biomaterials 2003, 24 (17), 2889–2894.
    OpenUrlPubMed
  32. 32.↵
    1. Tan Q.,
    2. Ji J.,
    3. Barbosa M. A.,
    4. Fonseca C.,
    5. Shen J.
    Constructing thromboresistant surface on biomedical stainless steel via layer-by-layer deposition anticoagulant. Biomaterials 2003, 24 (25), 4699–4705.
    OpenUrlPubMed
  33. 33.↵
    1. Yoshioka T.,
    2. Tsuru K.,
    3. Hayakawa S.,
    4. Osaka A.
    Preparation of organotitanium molecular layers for biomedical applications. Materials Science and Engineering C 2004, 24 (6–8), 901–904.
    OpenUrl
  34. 34.↵
    1. Kainthan R. K.,
    2. Hester S. R.,
    3. Levin E.,
    4. Devine D. V.,
    5. Brooks D. E.
    In vitro biological evaluation of high molecular weight hyperbranched polyglycerols. Biomaterials 2007, 28 (31), 4581–4590.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Sevastianov V. I.,
    2. Perova N. V.,
    3. Shishatskaya E. I.,
    4. Kalacheva G. S.,
    5. Volova T. G.
    Production of purified polyhydroxyalkanoates (PHAs) for applications in contact with blood. J. Biomater. Sci. Polym. Ed. 2003, 14 (10), 1029–1042.
    OpenUrlPubMed
  36. 36.↵
    1. Mikhailovskii A. G.,
    2. Vikhareva E. V.,
    3. Ismailova N. G.,
    4. Syropyatov B. Y.,
    5. Vakhrin M. I.
    Synthesis and blood coagulation properties of drotaverine derivatives. Pharmaceutical Chemistry Journal 2007, 41 (10), 529–31.
    OpenUrl
  37. 37.↵
    1. Yan J.,
    2. Mi J. Q.,
    3. He J. T.,
    4. Guo Z. Q.,
    5. Zhao M. P.,
    6. Chang W. B.
    Development of an indirect competitive ELISA for the determination of papaverine. Talanta 2005, 66 (4), 1005–1011.
    OpenUrlPubMed
  38. 38.↵
    1. Engstörm M.,
    2. Schött U.,
    3. Rommer B.,
    4. Reinstrup P.
    Acidosis impairs the coagulation: a thromboelastographic study. J. Trauma 2006, 61 (3), 624–628.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In This Issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Preparation and Characterization of Papaverine-Loaded Poly[(R)-3-Hydroxybutyrate] Membranes To Be Used in the Prevention of Vasospasm
Eylem Güven, Eşref Oǧuz Güven, Cem Bayram, Osman Nuri Kazak, Emir Baki Denkbaş
PDA Journal of Pharmaceutical Science and Technology Jul 2010, 64 (4) 316-326;
Twitter logo Facebook logo Mendeley logo

Jump to section